EUVIMEDEUVIMED entdecken
Crossref

Treatment of pregnant mice with ABZ had no effect on the immune response of their offspring infected with Trichinella spiralis

Shuhui Fan, Yue Wang, Ruigeng Ma, Tianming Niu, Boshi Zou, Yu Quan, Huinan Lu, Zhiyu Zhu, Chunwei Shi, Wentao Yang, Yanlong Jiang, Xin Cao und 6 weitere

International Immunopharmacology · 2023

DOI: 10.1016/j.intimp.2023.110568 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Shuhui Fan und 17 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, Jilin Agricultural University, Changchun, China; Jilin Provincial Engineering Research Center of Animal Probiotics, J…. Hauptthemen laut MEDLINE: Trichinella spiralis, Trichinellosis. Die Arbeit nennt 43 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Agriculture Research System of China, Jilin Scientific and Technological Development Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Trichinellosis is a food-borne parasitic disease with a worldwide distribution that not only endangers human health but also leads to economic loss. Infection of pregnant animals with Trichinella spiralis (T. spiralis) may lead to abortion and other adverse consequences, so it is necessary to treat the infection during pregnancy. Albendazole (ABZ) is an effective therapeutic drug for adult T. spiralis worms. The safety of this drug during pregnancy, especially whether it has any effect on offspring, should be fully evaluated. A change in the immune response to T. spiralis in the offspring of pregnant mice treated with ABZ may lead to a difference in susceptibility to T. spiralis compared to that of the offspring of normal mice. However, the safety of ABZ treatment in pregnant mice and the effects on the immune response and susceptibility of their offspring to T. spiralis are poorly understood. Therefore, we assessed whether maternal ABZ treatment during pregnancy affects the immune response or susceptibility to T. spiralis in infected offspring. In this study, mice were infected with T. spiralis at 10 days of pregnancy and treated with ABZ at 3 days post infection (dpi), and the specific immune response in the pregnant mice and the survival rate and worm burden of their 6-week-old offspring after T. spiralis infection were examined. The results showed that the antiparasitic immune response in pregnant mice was activated by T. spiralis infection. Treatment of pregnant mice with ABZ increased the percentage of CD4 + T cells. The percentages of Th2 and Treg cells in the PP, MLN and spleen of pregnant mice in the infection group were significantly increased compared with those of normal mice. ABZ treatment during pregnancy promoted the Th2 and Treg immune responses in pregnant mice infected with T. spiralis. The transcriptional levels of the Th2 and Treg cytokines IL-4, IL-5, IL-13, and TGF-β in the small intestine, MLN and spleen of pregnant mice in the treatment group were significantly higher than those of pregnant mice in the T. spiralis infection only group. The results indicated that ABZ treatment did not cause abortion in pregnant mice or affect the survival rate of their offspring. Furthermore, treatment of pregnant mice with ABZ had no significant effect on the above immune responses in their T. spiralis-infected offspring compared to those of T. spiralis-infected offspring of mice in the normal group. The results also indicated that treatment of pregnant mice infected with T. spiralis with ABZ shifted the immune response to a Th2- and Treg-skewed immune response and that this drug had no effects on the offspring survival rate, immune response or worm burden after T. spiralis infection. This study further indicated that ABZ administration to treat T. spiralis infection in pregnant mice is safe for the select immune response and susceptibility of their offspring.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Trichinella spiralisTrichinellosisPregnancyFemaleHumansMiceAnimalsAlbendazoleCytokinesImmunity

Stichwörter der Autor:innen

AlbendazoleImmune responsePregnant miceTrichinella spiralis

Substanzen

AlbendazoleCytokines

Autor:innen und Institutionen

  • College of Veterinary Medicine, Jilin Agricultural University, Changchun, China; Jilin Provincial Engineering Research Center of Animal Probiotics, Jilin Agricultural University, Changchun, China; Key Laboratory of Anim…

Förderung

  • National Natural Science Foundation of China
  • Agriculture Research System of China
  • Jilin Scientific and Technological Development Program

Zitieren

APA

Fan, S., Wang, Y., Ma, R., Niu, T., Zou, B., Quan, Y., Lu, H., Zhu, Z., Shi, C., Yang, W., Jiang, Y., Cao, X., Wang, J., Huang, H., Zeng, Y., Wang, N., Yang, G., & Wang, C. (2023). Treatment of pregnant mice with ABZ had no effect on the immune response of their offspring infected with Trichinella spiralis. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.110568

Vancouver

Fan S, Wang Y, Ma R, Niu T, Zou B, Quan Y, et al. Treatment of pregnant mice with ABZ had no effect on the immune response of their offspring infected with Trichinella spiralis. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.110568

BibTeX
@article{Fan2023,
  author = {Fan, Shuhui and Wang, Yue and Ma, Ruigeng and Niu, Tianming and Zou, Boshi and Quan, Yu and Lu, Huinan and Zhu, Zhiyu and Shi, Chunwei and Yang, Wentao and Jiang, Yanlong and Cao, Xin and Wang, Jianzhong and Huang, Haibin and Zeng, Yan and Wang, Nan and Yang, Guilian and Wang, Chunfeng},
  title = {Treatment of pregnant mice with ABZ had no effect on the immune response of their offspring infected with Trichinella spiralis},
  journal = {International Immunopharmacology},
  year = {2023},
  doi = {10.1016/j.intimp.2023.110568}
}
Kostenlos starten →